4 completed, 1 terminated. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Horton's Disease: new trials by email Literature Review of Horton's Disease trials Research Report on Horton's Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COVID-19 Related Lockdown Effects On Chronic Diseases life questionnaires, questionnaire - Chronic Coronary Syndrome, Heart Failure | Completed | Centre Hospitalier Universitaire Dijon | 1343 | 2020-04-14 | 2026-02-02 | |
| Ustekinumab for the Treatment of Giant Cell Arteritis Ustekinumab, Prednisone - Giant Cell Arteritis, Temporal Arteritis | Phase 1 / Phase 2 | Terminated | Massachusetts General Hospital | 13 | 2016-12-01 | 2020-06-12 |
| Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease Blood samples - Horton's Disease | Not applicable | Completed | Centre Hospitalier Universitaire Dijon | 41 | 2015-10-05 | 2026-02-06 |
| Study of the T CD8 Immune Response in Horton's Disease Blood sample drawn into a 5 mL dry tube at the diagnosis and after 3 months of treatment, 16 blood samples drawn into 6 mL heparinized tubes at the diagnosis and after 3 months of treatment, Blood sample drawn into a 5 mL dry tube - Horton's Disease | Completed | Centre Hospitalier Universitaire Dijon | 30 | 2013-07-25 | 2026-03-12 | |
| Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD) 1 blood sample, 2 to 3 blood samples (at inclusion, at 3 months and at 6 months in cases of relapse) - Horton's Disease, Infectious Disease | Completed | Centre Hospitalier Universitaire Dijon | 143 | 2009-07-28 | 2019-05-06 |
Giant Cell Arteritis (5) · Communicable Diseases (1) · Heart Failure (1) · Hemophilia A (1) · Macular Edema (1) · Multiple Sclerosis (1) · Neoplasms (1)
Arteritis (5) · Autoimmune Diseases (5) · Autoimmune Diseases of the Nervous System (5) · Brain Diseases (5) · Cardiovascular Diseases (5) · Central Nervous System Diseases (5) · Cerebrovascular Disorders (5) · Immune System Diseases (5) · Nervous System Diseases (5) · Skin Diseases (5) · Skin Diseases, Vascular (5) · Skin and Connective Tissue Diseases (5) · Vascular Diseases (5) · Vasculitis (5) · Vasculitis, Central Nervous System (5)
Blood Specimen Collection (1) · Prednisone (1) · Surveys and Questionnaires (1) · Therapeutics (1) · Ustekinumab (1)
Centre Hospitalier Universitaire Dijon (4) · Massachusetts General Hospital (1)
France (4) · United States (1)
PMID 32866179, PMID 27236507, PMID 32248659, PMID 34532040, PMID 35238436, PMID 35409640